Locomotor differences in mice expressing wild-type human α-synuclein.

Neurobiol Aging

Department of Neuroscience, and CTRND, McKnight Brain Institute, University of Florida, Gainesville, FL, USA. Electronic address:

Published: May 2018

Parkinson's disease manifests as a progressive movement disorder with underlying degeneration of dopaminergic neurons in the substantia nigra, consequent depletion of dopamine levels, and the accumulation of Lewy bodies in the brain. Because α-synuclein (α-Syn) protein is the major component of Lewy bodies, mouse models expressing wild-type or mutant SNCA/α-Syn genes provide a useful tool to investigate canonical characteristics of the disease. We evaluated a mouse model (denoted M20) that expresses human wild-type SNCA gene. The M20 mice showed abnormal locomotor behavior and reduced species-specific home cage activity. However, the direction of behavioral changes was task specific. In comparison with their control littermates, the M20 mice exhibited shorter grip endurance, and longer times to traverse elevated beams, but they descended the vertical pole faster and stayed longer on the accelerated rod than the control mice. The M20 mice were also impaired in burrowing and nest building activities. These results indicate a possible role of α-Syn in motor coordination and the motivation to perform species-specific behaviors in the presymptomatic model of synucleinopathy.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5871592PMC
http://dx.doi.org/10.1016/j.neurobiolaging.2018.01.020DOI Listing

Publication Analysis

Top Keywords

m20 mice
12
expressing wild-type
8
lewy bodies
8
mice
5
locomotor differences
4
differences mice
4
mice expressing
4
wild-type human
4
human α-synuclein
4
α-synuclein parkinson's
4

Similar Publications

Permanent preservation of genetic resources may be indispensable for the future of humanity. This requires liquid nitrogen, as is the case for preserving animal sperm. However, this technique is expensive and poses a risk of irrecoverable sample loss on non-replenishment of liquid nitrogen in case of natural disasters.

View Article and Find Full Text PDF

(1) Background: This study investigated the impact of in vitro adaptations to acid and bile stress on the cholesterol-lowering activity of the probiotic Lactobacillus kefir M20. (2) Methods: Lactobacillus kefir M20 was extracted from fermented dairy products in Xinjiang, China, and isolated using MRS medium. The lactic acid bacteria were cultured for stress resistance to acid and bile salts and then gavaged into mice for animal experiments.

View Article and Find Full Text PDF

MicroRNA-142 regulates gut associated lymphoid tissues and group 3 innate lymphoid cells.

Mucosal Immunol

September 2024

Lydia Becker Institute of Immunology and Inflammation, University of Manchester, M13 9PL, United Kingdom; Centre for Gene Therapy and Regenerative Medicine, School of Basic and Medical Biosciences, Faculty of Life Sciences and Medicine, King's College London, United Kingdom. Electronic address:

Article Synopsis
  • * Deleting the Mir142 gene leads to changes in intestinal ILC populations, notably missing T-bet cells and altering ILC3 characteristics, which is linked to reduced colitis severity and impaired development of gut-associated lymphoid tissues.
  • * The research identifies miR-142 as a key regulator in ILC3s, impacting their cellular behavior in the gut, while also increasing IL-17A production when Mir142 is absent, highlighting its critical role in intestinal immune responses.
View Article and Find Full Text PDF
Article Synopsis
  • Parkinson's disease (PD) is marked by the loss of dopamine neurons and α-synuclein (α-Syn) buildup, but the exact mechanisms behind these processes are still unclear.
  • Research indicates that the PM20D1 gene, linked to PD, plays a role in converting dopamine into N-arachidonoyl dopamine (NADA), which helps prevent α-Syn from clumping together.
  • Studies showed that enhancing PM20D1 expression or giving NADA to mice improved α-Syn-related damage and motor skills, suggesting this pathway could protect against PD progression.
View Article and Find Full Text PDF

Background: Pharmacotherapy for brain diseases is severely compromised by the blood-brain barrier (BBB). ABCB1 and ABCG2 are drug transporters that restrict drug entry into the brain and their inhibition can be used as a strategy to boost drug delivery and pharmacotherapy for brain diseases.

Methods: We employed elacridar and tariquidar in mice to explore the conditions for effective inhibition at the BBB.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!